© 2020 MJH Life Sciences and Medical Economics. All rights reserved.
© 2020 MJH Life Sciences™ and Medical Economics. All rights reserved.
2017 has seen two key advancements for diabetes patients, but affordability remains an issue.
Glucose lowering drugs provide additional cardiovascular benefit to patients with diabetes.
Diabetes and high BMI were responsible for an estimated 800,000 new cases of cancer worldwide in 2012.
Study shows that longer sleep duration was associated with reductions in several markers for type 2 diabetes.